ghk-cu administration subcutaneous Dosing: 1.7mg/Day Injectable (2026) GHK-CU Peptide Dosage: Complete Guide

It's not as simple as legal or illegalthis peptide exists in a limbo of regulatory language, safety concerns, and shifting enforcement priorities

The 5/2 daily protocol is what most published research describes

A total of 71 articles were included in qualitative synthesis

Tirzepatide as an alternative Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 agonist that some research suggests may preserve muscle better than semaglutide

[DOI] [PubMed] [Google Scholar] Riley 2011 Riley RD, Higgins JP, Deeks JJ

This initial consultation removes all the guesswork and sets you on a clear path, whether youre addressing a deficiency or simply aiming for a wellness boost